IWN
AKBA icon

Independent Wealth Network’s Akebia Therapeutics AKBA Stock Holding History

Independent Wealth Network’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$3.25K – 216
2024
Q1 		$3.25K Buy
+10,000
New +$16K ﹤0.01% 223

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Independent Wealth Network's AKBA Position: Q1 2026 in Review

Independent Wealth Network held its Akebia Therapeutics (AKBA) position steady in Q1 2026 at 13,003 shares worth $18.1K. The position accounts for 0.01% of the portfolio, ranked #299.

Independent Wealth Network first reported a position in AKBA in Q1 2024 and has held it in 9 quarters since. The position peaked at $47.3K in Q2 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Independent Wealth Network held 13,003 shares of Akebia Therapeutics worth $18.1K as of Q1 2026.
  • Independent Wealth Network left its Akebia Therapeutics share count unchanged in Q1 2026.
  • Akebia Therapeutics made up 0.01% of Independent Wealth Network's portfolio in Q1 2026, its #299 holding.
  • Independent Wealth Network first reported a position in Akebia Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Independent Wealth Network's Akebia Therapeutics position peaked at $47.3K in Q2 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Independent Wealth Network's 13F filing for Q1 2026, filed 21 Apr 2026.